References
- Owen K, Hattersley AT. Maturityonset diabetes of the young: from clinical description to molecular genetic characterization. Best Pract Res Clin Endocrinol Metab 2001; 15: 309-323.
- Shepherd M, Sparkes AC, Hattersley AT, . Genetic testing in maturity onset diabetes of the young (MODY): a new challenge for the diabetic clinic Pract Diab Int 2001; 18: 16–21.
- Tattersall RB. Mild familial diabetes with dominant inheritance. QJ Med 1974; 43: 339–357.
- Byrne MM, Stuns J, Menzel S, et al. Altered insulin secretory responses to glucose in diabetic and nondia-betic subjects with mutations in the diabetes susceptibility gene MODY3 on chromosome 12. Diabetes 1996; 45: 1503–1510.
- Owen KR, Shepherd M, Stride A, et al. Heterogeneity in young adult onset diabetes: aetiology alters clini-cal characteristics. Diabet Med 2002; 19: 758–761.
- Stride A, Ayres S, Allen LI, et al. Glycosuria at 2 h post OGTT: a screening tool for unaffected sub-jects in families with HNF-1 a muta-tions. Diabet Med 2002; 19 (Suppl 2): 59–60.
- Pearson ER, Starkey BJ, Powell RJ, et al. Genetic cause of hyperglycaemia and response to treatment in dia-betes. Lancet 2003; 362: 1275–1281.
- Tuomi T, Honkanen EH, Isomaa B, et al. Improved prandial glucose control with lower risk of hypo-glycemia with nateglinide than with glibenclamide in patients with maturity-onset diabetes of the young type 3. Diabetes Care 2006; 29: 189–194.
- Shepherd M, Pearson ER, Houghton J, et al. No deterioration in glycemic control in HNF-1 alpha maturity-onset diabetes of the young following transfer from long-term insulin to sulphonylureas. Diabetes Care 2003; 26: 3191–3192.
- Liljestrom B, Tuomi T, Isomaa B, et al. Adolescents at risk for MODY3 diabetes prefer genetic testing before adulthood. Diabetes Care 2007; 30: 1571–1573.
- Shepherd M, Ellis I, Ahmad AM, et al. Predictive genetic testing in maturity-onset diabetes of the young (MODY). Diabet Med 2001; 18: 417–421.
- Shepherd M, Hattersley AT, Sparkes AC, Predictive genetic testing in diabetes: a case study of multiple perspectives. Qual Health Res 2000; 10: 242–259.
- Edghill EL, Bingham C, Ellard S, Hattersley AT. Mutations in hepato-cyte nuclear factor-lbeta and their related phenotypes. J Med Genet 2006; 43: 84–90.
- Stride A, Vaxillaire M, Tuomi T, et al. The genetic abnormality in the beta cell determines the response to an oral glucose load. Diabetologia 2002; 45: 427–435.